Study Detail: SCORE

Trial Description Summary

The study is designed to find out if injection(s) of steroid into the eye are safe and effective in the treatment of macular edema secondary to central retinal vein occlusion (CRVO) or branch retinal vein occlusion (BRVO) compared to standard treatment.

Basic Trial Information

Study Duration: Three years

Eligibility Criteria

Inclusion Criteria

• Subjects must be willing and able to come in for a minimum of 10 to 12 visits over a 3 year period
• Many other criteria-Please contact coordinator

Exclusion Criteria

• Diagnosis of CRVO or BRVO greater than 24 months prior to screening
• Please check with the clinical coordinator for other exclusion criteria

Study Title: SCORE 

The standard care versus corticosteroid for retinal vein occlusion (SCORE) study:  Two randomized trials to compare the efficacy and safety of intravitreal injection(s) of triamcinolone acetonide with standard care to treat macular edema:  one for central retinal vein occlusion (CRVO) and one for branch retinal vein occlusion (BRVO).

Trial Contact Information